The Board of Pharmacy adopted Temporary Rule OAR 855-007-0088 related to Compliance with Oregon Health Authority’s COVID Rules, effective October 18.
Also in Oregon, the Board of Pharmacy has proposed to permanently adopt numerous rules outlined below. Note: written comments may be submitted via email to pharmacy.rulemaking@bop.oregon.gov before 4:30 p.m. on November 23.
- Division 007 – related to Compliance with OHA COVID Rules
- Division 007/041/045/065 – related to USP, Storage, Labeling, Repackaging
- Division 010 – related to Board Administration & Policies
- Division 019/139 – related to Remote Dispensing Site Pharmacy
- Division 041/080 – related to Pseudoephedrine/Ephedrine
- Division 019/021 – related to Pain Management CE
- Division 020 – related to Pharmacist Prescriptive Authority – COVID mAb, PEP & PrEP
- Division 043 – related to SPDO/DPDO/CHC
- Division 060/110 – related to PDMP Fee Increase
- Division 006/041 – related to Telework, Remote Processing & TCVP
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.